With the upregulation of PD-L1 expression on tumor cells, it will produce adaptive resistance to IFN-γ released by cytotoxic T lymphocytes, thus forming a vicious cycle that aggravates disease progression and produces primary resistance to ICIs treatment. Here, IFNG is linked to neoplasm.